ARCHIVES

AGS-003 Immunotherapy Induces T Cell Responses in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Concept For BRMP Master Agreement

June 26, 1987

Chest X-Ray Produces Many False-Positive Results

January 27, 2006

Phase III Kyprolis Trial Fails OS Primary Endpoint

August 29, 2014

Unorthodox Panel Considers NIH Mandated Role In Study of Unconventional Medical Practices

June 26, 1992

CALGB Says Results In Adjuvant Setting Too Preliminary; Follow Up Planned In Three Years

April 16, 1999

Analysis Shows No Mortality Benefit From Regular PSA Screening

January 27, 2012